611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

NurseWise 24-Hour Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
Only Select Incidental Thyroid Nodules Need Further EvaluationTravelers Bring Malaria Back to U.S., With High CostsThe Top 5 Conditions That Shorten Americans' Lives -- And Are PreventableHealth Tip: Dealing With Foot ArthritisCDC: Salmonella Infection Prevalence Down in 2016Do Diet Sodas Pose Health Risks?Hantavirus Pulmonary Syndrome Risk Up for Some PopulationsHealth Tip: When Asthma Doesn't ImproveHealth Tip: Help Manage ConstipationChagas Disease Presents Public Health Challenge in the U.S.FDA Approves Device to Help Curb Cluster HeadachesReview: Interventions Don't Promote Exercise in Rural AdultsDiffering Statin Guidelines Leave Many Clinicians UncertainIllness From 'Kissing Bug' Now Widespread in U.S.Conflicting Statin Guidelines Leave Millions in 'Gray Zone'No Link Between Common Antibiotic, Irregular HeartbeatEpilepsy: Another Potential Zika Threat to BabiesUveitis Risk Higher Among Individuals With PsoriasisOne in Five Post-Op Patients Need Unscheduled HelpNew Bowel Disorder Treatments Needed, FDA SaysWhat's the Best Seasonal Allergy Med for Your Kid?Another Type of Mosquito May Carry ZikaCould a Daily Vitamin Curb Smog's Effect on the Heart?Accurate Diagnosis of Endocrine Hypertension ImportantKidney Disease a Big Contributor to Heart-Related Deaths: StudyOverweight, Underweight Both Tied to MigrainesDon't Let Ticks Get Under Your SkinSpecific Factors Influence First-Line Biologic Rx for PsoriasisA Healthier Weight May Mean Fewer MigrainesDiabetes Continues Its Relentless Rise1st Drug for Tardive Dyskinesia ApprovedHealth Tip: When to Worry About Neck PainChemicals Found in Many U.S. Streams: StudyAHA: Patients Lack Confidence in Managing Their CholesterolAsymptomatic C. difficile Ups Risk for Other Hospital PatientsSilk Clothes Won't Soothe Eczema's ItchHealth Tip: Recognizing Symptoms of Lactose IntoleranceHealth Tip: Should You Be Tested for Kidney Disease?Many Americans Don't Know How to Handle High CholesterolBotox May Help Ease 'Burning Mouth' SyndromeInsulin Resistance Predicts Later Cognitive DeclineMusic Therapy Relieves Post-Op Pain in Spinal Surgery PatientsLower Risk of Gastrointestinal Bleeding for ApixabanBedbugs Building Resistance to More InsecticidesObesity May Make Rheumatoid Arthritis Tough to Spot, TrackXanax, Valium May Boost Pneumonia Risk in Alzheimer's PatientsU.S. Blood Banks Can Protect Blood Supply From Zika VirusHow to Protect Yourself From Air PollutionIntestinal Reovirus Infection May Be Cause of Celiac DiseaseFDA Approves Hep C Drugs for Kids 12 and Older
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

FDA Approves Hep C Drugs for Kids 12 and Older

HealthDay News
by -- Scott Roberts
Updated: Apr 7th 2017

FRIDAY, April 7, 2017 (HealthDay News) -- The U.S. Food and Drug Administration has approved two drugs to treat hepatitis C infection in children aged 12 and older.

Both Solvaldi (sofosbuvir) and Harvoni (ledipasvir, sofosbuvir) are already approved for use in adults, the agency said in a news release Friday.

The medications are antivirals that prevent the hepatitis C virus (HCV) from reproducing. "In most cases, they cure HCV," the FDA added.

"These approvals will help change the landscape for HCV treatment by addressing an unmet need in children and adolescents," said Dr. Edward Cox, director of the Office of Antimicrobial Products in the FDA's Center for Drug Evaluation and Research.

Hepatitis C causes liver inflammation that can lead to liver failure. Between 3 and 4 million people in the United States are infected with the virus, the agency said.

Children born to infected mothers are at higher risk of being infected, the FDA said, noting there are an estimated 23,000 to 46,000 children in the United States with hepatitis C.

In clinical studies, the most common side effects of both drugs were fatigue and headache.

People taking hepatitis C antivirals who are also infected with hepatitis B have a greater risk of serious liver problems or death. This can happen because the hepatitis B virus can be reactivated if patients are not also taking antivirals to stem the hepatitis B infection.

Harvoni and Sovaldi are marketed by Gilead Sciences Inc., in Foster City, Calif.

More information

Visit the FDA to learn more.